MENVEO

Riik: Indoneesia

keel: indoneesia

Allikas: Badan Pengawas Obat dan Makanan RI - Indonesian Food and Drug Supervisory Agency

Toote omadused Toote omadused (SPC)
01-01-2018

Toimeaine:

MENINGOCOCCAL POLYSACCHARIDE GROUP A CONJUGATED TO CRM197 PROTEIN, MENINGOCOCCAL POLYSACCHARIDE GROUP C CONJUGATED TO CRM197 PROTEIN, MENINGOCOCCAL POLYSACCHARIDE GROUP W CONJUGATED TO CRM 197 PROTEIN, MENINGOCOCCAL POLYSACCHARIDE GROUP Y CONJUGATED TO CR

Saadav alates:

SMITHKLINE BEECHAM PHARMACEUTICALS - Indonesia

INN (Rahvusvaheline Nimetus):

MENINGOCOCCAL POLYSACCHARIDE GROUP A CONJUGATED TO CRM197 PROTEIN, MENINGOCOCCAL POLYSACCHARIDE GROUP C CONJUGATED TO CRM197 PROTEIN, MENINGOCOCCAL POLYSACCHARIDE GROUP W CONJUGATED TO CRM 197 PROTEIN, MENINGOCOCCAL POLYSACCHARIDE GROUP Y CONJUGATED TO CR

Annus:

10 µG MENA OLIGOSACCHARIDE 16.7-33.3 µG CRM197 MCG /5 µG MENC OLIGOSACCHARIDE 7.1-12.5 µG CRM197 MCG

Ravimvorm:

SERBUK INJEKSI

Ühikuid pakis:

DUS, 1 DOSIS @ (1 VIAL SERBUK INJEKSI + 1 VIAL LARUTAN INJEKSI @ ...

Valmistatud:

GLAXOSMITHKLINE VACCINES S.R.L - Italy

Loa andmise kuupäev:

2021-05-24

Vaadake dokumentide ajalugu